Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Clinical trial NCT05563844 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05563844
- Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2026-12-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.